Patent application number | Description | Published |
20090278571 | DEVICE AND TECHNIQUE FOR TRANSISTOR WELL BIASING - A method includes receiving a set of voltages comprising at least a first voltage, a second voltage, and a third voltage and biasing a well of a transistor based on the extreme voltage of the set of voltages. Biasing the well of the transistor can include concurrently providing a first signal and a second signal based on a comparison of the first voltage and the second voltage and selectively coupling the well of the transistor to a source of the extreme voltage of the set of voltages based on the first signal, the second signal, and the third voltage. An electronic device comprises a transistor and a power switching module. The power switching module includes a set of inputs, each input configured to receive a corresponding one of a set of voltages comprising at least a first voltage, a second voltage, and a third voltage, and includes an output coupled to a well of the transistor, the output configured to provide the extreme voltage of the set of voltages. | 11-12-2009 |
20130086283 | INTERFACE SYSTEM AND METHOD WITH BACKWARD COMPATIBILITY - An interface including first and second transport protocol circuitry, a memory and a mode controller. The interface includes first and second physical interface types which are both selectively enabled to interface a set of pads. The first transport protocol circuitry is operative with the first type physical interface in a first mode and the second transport protocol circuitry is operative with the second type physical interface in a second mode. The memory stores a mode value indicative of the operating mode. The mode controller enables one of the physical interface types and a corresponding transport protocol based on the mode value. The first mode is the default mode, and the mode controller enables dynamic transition to the second mode. An escape indication may be enabled during the second mode for dynamic transition back to the first mode. Programmable timing values may be used to facilitate mode transitions. | 04-04-2013 |
20130343133 | SYSTEM AND METHOD FOR SOFT ERROR DETECTION IN MEMORY DEVICES - A system for detecting soft errors in a memory device includes a latch, a master flip-flop and a slave flip-flop. The latch receives input data (control and/or address signals) at the beginning of a memory operation in response to a rising edge of a first clock signal. The output of the latch is provided to the master flip-flop. The master flip-flop continuously receives and stores the latch output during the memory operation based on a second clock signal. The slave flip-flop receives and stores the output of the master flip-flop at the end of the memory operation based on the second clock signal. A comparator compares the input data with the output of the slave flip-flop to detect soft errors that occur during the memory operation. | 12-26-2013 |
20140300400 | COMPARATOR AND CLOCK SIGNAL GENERATION CIRCUIT - A comparator used in a clock signal generation circuit has first and second input transistors coupled to input signals of the comparator. First and second hysteresis transistors are coupled between the input transistors and an output stage of the comparator, and apply hysteresis to a comparison of the input signals. First and second hysteresis control transistors are coupled between the input transistors and the hysteresis transistors to isolate the hysteresis transistors from the input transistors under control of a hysteresis enable signal. | 10-09-2014 |
Patent application number | Description | Published |
20100039242 | APPARATUS AND METHOD FOR DATA COMMUNICATION OVER POWER LINES - A method and apparatus for transferring communication data over power lines, the power lines comprising multiple phase transmission lines and a neutral line. The method includes inserting the communication data between multiple lines, typically between the different phase lines and the neutral, and combining the communication data from any one of the lines, and transmitting the combined signal to multiple lines in a receiving premises. In this way the signal can be picked up from any power socket at the receiving premises irrespective of what line or phase it may be attached to. | 02-18-2010 |
20100073149 | SYSTEM, APPARATUS AND METHOD FOR ENABLING OPTIMAL COMMUNICATION OVER POWER LINES - A system, apparatus and method for communication signaling between sending terminals and receiving terminals over power lines, comprises a power level test message configuration unit associated with a respective sending terminal for configuring test signals to send to one or more of said receiving units to determine optimal transmission characteristics for communication between the terminals, the respective test signals being configured per transmission power level. A test message sending unit sends the configured test signals to the various neighboring terminals over the power lines, therefrom to determine optimal transmission power levels for transmission to the various neighboring units. | 03-25-2010 |
20100073192 | SYSTEM AND METHOD FOR PROVIDING AUTOMATED METER MANAGEMENT LAYER INTELLIGENCE TO A POWER LINE COMMUNICATIONS SYSTEM - A system and method are provided to enable automated broadband AMR, optionally in real time. The system may include an Automated Meter Management Server and an Automated Meter Reading Converter, wherein the Automated Meter Management Server utilizes data generated by a Poller Converter and a Name Server, to enable automated data collaboration between Automated Meter Reading meters and a Power Line Communications System. | 03-25-2010 |
Patent application number | Description | Published |
20090291094 | ANTIBODIES AND PROCESSES FOR PREPARING THE SAME - Provided herein are various processes for the improved production of antibody producing organisms, antibody producing tissues, antibody producing cells and antibodies. In certain embodiments, provided herein are methods for rapidly producing antibody producing organisms, tissues, cells and antibodies derived from humans, organisms, plants or cells that are genetically altered to over-express certain proteins. | 11-26-2009 |
20100047217 | DIFFERENTIATED ANUCLEATED CELLS AND METHOD FOR PREPARING THE SAME - Provided herein are methods for preparing differentiated cells, and the cells prepared by such methods. | 02-25-2010 |
20100055129 | MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF INDENTIFIYING AGENTS THAT MODULATE MYC - Disclosed herein are methods of modulation of the viability of a cell. Further disclosed herein are methods of modulating an immune response. Further disclosed herein are methods of identifying agents capable of modulation of the viability of a cell or an immune response. Further disclosed herein are agents and compositions capable of modulation of the viability of a cell or an immune response. | 03-04-2010 |
20100183622 | VPR FUNCTION AND ACTIVITY - Pharmaceutical compositions comprising the HIV protein vpr or nucleic acid molecule encoding vpr are disclosed. Also disclosed are methods of treating patients suffering from diseases characterized by hyperproliferating undifferentiated cells such as cancer by administering such compositions. Methods of identifying compounds which have anti-HIV activity are disclosed, in particular, methods of identifying compounds which modulate the activity of vpr and of identifying compounds which inhibit vpr binding to the HIV protein gag. | 07-22-2010 |
20100279351 | Method for Generation of Antibodies - This invention generally relates to methods for the production of antibody producing cells and antibodies in protooncogene expressing animals. The invention also relates to methods for the efficient production of antibodies specific for antigens that are normally subject to immunological constraints such as self tolerance. The invention further relates to the production of antibody producing cells and antibodies without the need for the conventional fusing of antibody producing B cells with a myeloma fusion partner. | 11-04-2010 |
20100297763 | CONDITIONALLY IMMORTALIZED LONG-TERM STEM CELLS AND METHODS OF MAKING AND USING SUCH CELLS - Disclosed are methods for conditionally immortalizing stem cells, including adult and embryonic stem cells, the cells produced by such methods, therapeutic and laboratory or research methods of using such cells, and methods to identify compounds related to cell differentiation and development or to treat diseases, using such cells. A mouse model of acute myeloid leukemia (AML) and cells and methods related to such mouse model are also described. | 11-25-2010 |
20110218210 | COMPOUNDS FOR TREATING ABNORMAL CELLULAR PROLIFERATION - Provided herein are compounds, compositions and methods for treating disorders mediated by abnormal cellular proliferation and processes for identifying such compounds. | 09-08-2011 |
20110263820 | ANTIBODIES AND PROCESSES FOR PREPARING THE SAME - Provided herein are various processes for the improved production of antibody producing organisms, antibody producing tissues, antibody producing cells and antibodies. In certain embodiments, provided herein are methods for rapidly producing antibody producing organisms, tissues, cells and antibodies derived from humans, organisms, plants or cells that are genetically altered to over-express certain proteins. | 10-27-2011 |
20130177586 | MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC - Disclosed herein are methods of modulation of the viability of a cell. Further disclosed herein are methods of modulating an immune response. Further disclosed herein are methods of identifying agents capable of modulation of the viability of a cell or an immune response. Further disclosed herein are agents and compositions capable of modulation of the viability of a cell or an immune response. | 07-11-2013 |
20130267456 | THERAPEUTIC APPLICATIONS OF SMAD7 - The invention provides methods and compositions for the treatment of inflammatory and/or tissue damage conditions. In particular, the use of Smad7 compositions delivered locally or systemically to a site of inflammation and/or tissue damage is described. Other specific embodiments concern treatment or prevention of side effects caused by radiation and/or chemotherapy, including but not limited to mucositis. | 10-10-2013 |
20140109246 | METHODS OF GENERATING XENOCHIMAERIC MICE WITH TUMOR AND HEMATOPOIETIC SYSTEM FROM THE SAME HETEROLOGOUS SPECIES - The present invention provides methods for the generation of xenochimaeric animals; for example, xenochimaeric mice, comprising bone marrow progenitor cells and tumors from a heterologous animal. In some aspects, the invention provides xenochimaeric mice bearing humanized bone marrow and human tumors. Such animals are a model system for the study of human tumor stroma, for drug discovery, and for the treatment of human cancers. | 04-17-2014 |
20140162357 | METHODS FOR GENERATION OF ANTIBODIES - This invention generally relates to methods for the production of antibody producing cells and antibodies in protooncogene expressing animals. The invention also relates to methods for the efficient production of antibodies specific for antigens that are normally subject to immunological constraints such as self tolerance. The invention further relates to the production of antibody producing cells and antibodies without the need for the conventional fusing of antibody producing B cells with a myeloma fusion partner. | 06-12-2014 |
20140255369 | PRODUCTION AND USE OF RED BLOOD CELLS - The present disclosure relates to the production of red blood cells from hematopoietic stem cells, by differentiating such cells in the presence of a protein that induces cell survival and proliferation. | 09-11-2014 |
20140273212 | EXPANSION OF ADULT STEM CELLS IN VITRO - Disclosed are methods for manipulating and expanding stem cell populations, including adult stem cells, the cells produced by such methods, and various protein constructs related thereto. | 09-18-2014 |
20140288006 | PTD-SMAD7 THERAPEUTICS - The present technology provides methods and compositions for the treatment of inflammatory and/or tissue damage conditions. In particular, the use of Smad7 compositions delivered locally or systemically to a site of inflammation and/or tissue damage is described. Other specific embodiments concern treatment or prevention of side effects caused by radiation and/or chemotherapy, including but not limited to oral and gastric mucositis. Also provided are codon-optimized nucleic acids encoding for Smad7 fusion proteins. | 09-25-2014 |
20140356392 | MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC - Disclosed herein are methods of modulation of the viability of a cell. Further disclosed herein are methods of modulating an immune response. Further disclosed herein are methods of identifying agents capable of modulation of the viability of a cell or an immune response. Further disclosed herein are agents and compositions capable of modulation of the viability of a cell or an immune response. | 12-04-2014 |